By proceeding, you agree to our Terms of Use and Privacy Policy.
The 6th Antigen-Specific Immune Tolerance Summit returns as the definitive industry-dedicated forum bringing you the latest discoveries, preclinical, translational, and early clinical developments on tolerogenic therapies.
To gain insights into the latest discoveries and early clinical developments on tolerogenic therapies.
Delve into & tackle complex heterogenous diseases with multiple antigens and epitopes & investigate clinical endpoints and determinants of efficacy.
Explore the breadth of novel technologies and platforms for antigen delivery and navigate frequency of administration to transform tolerance strategies.
Connect with drug developers and researchers supercharging life-changing and ground-breaking antigen-specific immunotherapies.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Anokion SA is a Swiss biotechnology company that aims to make a meaningful difference in the lives of patients suffering from autoimmune diseases by restoring normal immune tolerance.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.